178 related articles for article (PubMed ID: 21087602)
1. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo.
Jang SH; Choi SY; Ryu PD; Lee SY
Eur J Pharmacol; 2011 Jan; 651(1-3):26-32. PubMed ID: 21087602
[TBL] [Abstract][Full Text] [Related]
2. Dendrotoxin-κ suppresses tumor growth induced by human lung adenocarcinoma A549 cells in nude mice.
Jang SH; Ryu PD; Lee SY
J Vet Sci; 2011 Mar; 12(1):35-40. PubMed ID: 21368561
[TBL] [Abstract][Full Text] [Related]
3. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.
Aissaoui D; Mlayah-Bellalouna S; Jebali J; Abdelkafi-Koubaa Z; Souid S; Moslah W; Othman H; Luis J; ElAyeb M; Marrakchi N; Essafi-Benkhadir K; Srairi-Abid N
Int J Biol Macromol; 2018 May; 111():1146-1155. PubMed ID: 29415410
[TBL] [Abstract][Full Text] [Related]
4. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
[TBL] [Abstract][Full Text] [Related]
5. Nuclear localization and functional characteristics of voltage-gated potassium channel Kv1.3.
Jang SH; Byun JK; Jeon WI; Choi SY; Park J; Lee BH; Yang JE; Park JB; O'Grady SM; Kim DY; Ryu PD; Joo SW; Lee SY
J Biol Chem; 2015 May; 290(20):12547-57. PubMed ID: 25829491
[TBL] [Abstract][Full Text] [Related]
6. Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer.
Jang SH; Kang KS; Ryu PD; Lee SY
BMB Rep; 2009 Aug; 42(8):535-9. PubMed ID: 19712592
[TBL] [Abstract][Full Text] [Related]
7. Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.
Schwartz AB; Kapur A; Wang W; Huang Z; Fardone E; Palui G; Mattoussi H; Fadool DA
J Neurochem; 2017 Feb; 140(3):404-420. PubMed ID: 27861889
[TBL] [Abstract][Full Text] [Related]
8. Effects of voltage-gated K+ channel blockers in gefitinib-resistant H460 non-small cell lung cancer cells.
Jeon WI; Ryu PD; Lee SY
Anticancer Res; 2012 Dec; 32(12):5279-84. PubMed ID: 23225427
[TBL] [Abstract][Full Text] [Related]
9. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
[TBL] [Abstract][Full Text] [Related]
10. Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo.
Koeberle PD; Wang Y; Schlichter LC
Cell Death Differ; 2010 Jan; 17(1):134-44. PubMed ID: 19696788
[TBL] [Abstract][Full Text] [Related]
11. Potassium secretion by voltage-gated potassium channel Kv1.3 in the rat kidney.
Carrisoza-Gaytán R; Salvador C; Satlin LM; Liu W; Zavilowitz B; Bobadilla NA; Trujillo J; Escobar LI
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F255-64. PubMed ID: 20427469
[TBL] [Abstract][Full Text] [Related]
12. Silencing of voltage-gated potassium channel KV9.3 inhibits proliferation in human colon and lung carcinoma cells.
Lee JH; Park JW; Byun JK; Kim HK; Ryu PD; Lee SY; Kim DY
Oncotarget; 2015 Apr; 6(10):8132-43. PubMed ID: 25924237
[TBL] [Abstract][Full Text] [Related]
13. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
[TBL] [Abstract][Full Text] [Related]
14. Kv1.3 blockade inhibits proliferation of vascular smooth muscle cells in vitro and intimal hyperplasia in vivo.
Bobi J; Garabito M; Solanes N; Cidad P; Ramos-Pérez V; Ponce A; Rigol M; Freixa X; Pérez-Martínez C; Pérez de Prado A; Fernández-Vázquez F; Sabaté M; Borrós S; López-López JR; Pérez-García MT; Roqué M
Transl Res; 2020 Oct; 224():40-54. PubMed ID: 32522668
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of Kv1.3 fails to modulate insulin sensitivity in diabetic mice or human insulin-sensitive tissues.
Straub SV; Perez SM; Tan B; Coughlan KA; Trebino CE; Cosgrove P; Buxton JM; Kreeger JM; Jackson VM
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E380-90. PubMed ID: 21586699
[TBL] [Abstract][Full Text] [Related]
16. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
Leanza L; O'Reilly P; Doyle A; Venturini E; Zoratti M; Szegezdi E; Szabo I
Curr Pharm Des; 2014; 20(2):189-200. PubMed ID: 23701546
[TBL] [Abstract][Full Text] [Related]
17. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation.
Villalonga N; Martínez-Mármol R; Roura-Ferrer M; David M; Valenzuela C; Soler C; Felipe A
Biochim Biophys Acta; 2008 May; 1783(5):728-36. PubMed ID: 18230363
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
[TBL] [Abstract][Full Text] [Related]
20. K+ channels expression in hypertension after arterial injury, and effect of selective Kv1.3 blockade with PAP-1 on intimal hyperplasia formation.
Cidad P; Novensà L; Garabito M; Batlle M; Dantas AP; Heras M; López-López JR; Pérez-García MT; Roqué M
Cardiovasc Drugs Ther; 2014 Dec; 28(6):501-11. PubMed ID: 25348824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
